pentadecapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized powder | Freeze-dried solid, often hygroscopic |
| Solubility class | Freely soluble in water | Aqueous buffers used for stock solutions |
| Storage, dry powder | Minus 20 °C or colder | Recommended for long-term retention |
| Storage, solution | 2–8 °C or frozen | Avoid repeated freeze-thaw cycles |
| Typical analytical method | RP-HPLC with mass spectrometry | Purity percentage plus mass confirmation |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
On 1 January 2006, FFA quit the OFC and joined the AFC. The move was unanimously endorsed by the AFC on 23 March 2005 and assented by the OFC on 17 April 2005. FIFA approved the move on 29 June, noting that "as all of the parties involved ... had agreed to the move, the case did not need to be discussed by the FIFA Congress". The move was unanimously ratified by the AFC on 10 September. FFA hoped that the move would give its teams a fairer chance of qualifying for the FIFA World Cup and allow A-League clubs to compete in the AFC Champions League thereby improving the standard of soccer in Australia at international and club levels, with improved competition in the region. In February 2008, FFA announced its intention to bid for the 2018 FIFA World Cup, 2022 FIFA World Cup and the 2015 AFC Asian Cup. In 2010, FFA decided to withdraw its World Cup bid for 2018, instead focusing on a bid for the 2022 tournament. FFA failed in its $45.6 million bid for the 2022 World Cup having received only one vote from the FIFA Executive. In 2012, a rival soccer competition organisation Football Australia was formed and occupied that name. On 27 August 2013, FFA was admitted as a full member to the ASEAN Football Federation (AFF), after it had become an invite affiliation to the regional body in 2006. However, its men's national team has not played in the ASEAN Championship as part of the initial agreement.
In the 1880s, while studying Beggiatoa (a bacterium living in a sulfur rich environment), Sergei Winogradsky found that it oxidized hydrogen sulfide (H2S) as an energy source, forming intracellular sulfur droplets. Winogradsky referred to this form of metabolism as inorgoxidation (oxidation of inorganic compounds). Another contributor, who continued to study it was Selman Waksman. Primitive bacteria that live around deep ocean volcanic vents oxidize hydrogen sulfide for their nutrition, as discovered by Robert Ballard. Sulfur oxidizers can use as energy sources reduced sulfur compounds, including hydrogen sulfide, elemental sulfur, sulfite, thiosulfate, and various polythionates (e.g., tetrathionate). They depend on enzymes such as sulfur oxygenase and sulfite oxidase to oxidize sulfur to sulfate. Some lithotrophs can even use the energy contained in sulfur compounds to produce sugars, a process known as chemosynthesis. Some bacteria and archaea use hydrogen sulfide in place of water as the electron donor in chemosynthesis, a process similar to photosynthesis that produces sugars and uses oxygen as the electron acceptor. Sulfur-based chemosynthesis may be simplifiedly compared with photosynthesis:
As with the North Tower, hundreds were killed at the moment of impact. Unlike those in the North Tower, the estimated 300 survivors of the crash were not technically trapped, but most were either unaware that a means of escape still existed or were unable to use it. One stairway, Stairwell A, narrowly avoided being destroyed, allowing 14 people located on the floors of impact, including Stanley Praimnath, a man who saw the plane coming at him, and four more from the floors above to escape. New York City 9-1-1 operators who received calls from people inside the tower were not well informed of the situation as it rapidly unfolded and as a result, told callers not to descend the tower on their own. In total, 630 people died in the South Tower, fewer than half the number killed in the North Tower. Of the 100–200 people witnessed jumping or falling to their deaths, only three recorded sightings were from the South Tower. Casualties in the South Tower were significantly reduced because some occupants decided to leave the building immediately following the first crash, and because Eric Eisenberg, an executive at AON Insurance, decided to evacuate the floors occupied by AON (92 and 98–105) following the impact of Flight 11. The 17-minute gap allowed more than 900 of the 1,100 AON employees present to evacuate from above the 77th floor before the South Tower was struck. Eisenberg was among the nearly 200 who did not escape. Similar pre-impact evacuations were carried out by Fiduciary Trust, CSC, and Euro Brokers, all of whom had offices on floors above the point of impact.
=== Polynuclear and heterobimetallic metallocenes === Ferrocene derivatives: biferrocenophanes have been studied for their mixed valence properties. Upon one-electron oxidation of a compound with two or more equivalent ferrocene moieties, the electron vacancy could be localized on one ferrocene unit or completely delocalized. Ruthenocene derivatives: in the solid state biruthenocene is disordered and adopts the transoid conformation with the mutual orientation of Cp rings depending on the intermolecular interactions. Vanadocene and rhodocene derivatives: vanadocene complexes have been used as starting materials for the synthesis of heterobimetallic complexes. The 18 valence electron ions [Cp2Rh]+ are very stable, unlike the neutral monomers Cp2Rh which dimerize immediately at room temperature and they have been observed in matrix isolation.
== Pharmacokinetics == Valsartan has an oral bioavailability of approximately 25% and reaches peak blood concentrations around 2–4 hours after ingestion. The estimated elimination half-life is determined to be approximately 6 hours, volume distribution of 17 litres, and a protein binding of 95% is seen. The elderly may see increases in half life of the drug by up to 35% but dosing adjustment will not typically be warranted, however the drug should be used with caution in severe liver or kidney impairment. Majority of the drug is eliminated through the feces (83%) while only a small portion is eliminated in the urine (13%). Most of the drug excreted is unchanged, only small portion of the drug is metabolized to its inactive form 4-hydroxyvaleryl valsartan, the enzyme suspected to be responsible for this is the liver enzyme CYP2C9. Hydrochlorothiazide has an oral bioavailability of 70% and reaches peak concentration around 1.5–2 hours following ingestion. The half-life is quite variable for this drug and can range from 5–15 hours. This drug is not metabolized and is mostly excreted unchanged in the urine (60-70%). Protein binding ranges between 40 and 70% and volume of distribution varies from 4-8L/kg.
Sources: en.wikipedia.org
== Humphreys' influence == Humphreys influenced generations of sociologists and other social and behavioral scientists in complex ways. He is often studied in research methods classes for the ethical questions that his works raised. However, Earl Babbie, who writes about sociological research methods, notes that the controversy about "sociological snoopers" and research ethics was likely the result of societal homophobia and disgust with the research topic, and not due to real problems with research methods. Schacht credits Humphreys with pioneering research on impersonal sex, now a common topic of research and advocacy in the context of HIV/AIDS. Tewksbury writes about the multiple studies that were inspired by Humphrey's work, calling his work a rich legacy for future sex researchers. According to Brekhus, Humphrey's contribution to sociological theory, in particular to the development of the concept of identity politics, is often overlooked, but should be hailed as an important forerunner to modern queer theory. Nardi also lauds Humphreys' theoretical work, especially his concept of the breastplate of righteousness. Humphreys developed this idea to explain the apparent contradiction of presumably straight, married men holding a public conservative stance against homosexuality, yet engaging in impersonal sex with men in public settings. In 2003, the presidential session at the Society for the Study of Social Problems (SSSP) was devoted to honoring Humphrey's pioneering work on sexuality.
Immediately after the atomic bombings of Japan, the status of atomic weapons in international and military relations was unclear. Presumably, the United States hoped atomic weapons could offset the Soviet Union's larger conventional ground forces in Eastern Europe, and possibly be used to pressure Soviet leader Joseph Stalin into making concessions. Under Stalin, the Soviet Union pursued its own atomic capabilities through a combination of scientific research and espionage directed against the American program. The Soviets believed that the Americans, with their limited nuclear arsenal, were unlikely to engage in any new world wars, while the Americans were not confident they could prevent a Soviet takeover of Europe, despite their atomic advantage. Within the United States, the authority to produce and develop nuclear weapons was removed from military control and put instead under the civilian control of the United States Atomic Energy Commission. This decision reflected an understanding that nuclear weapons had unique risks and benefits that were separate from other military technology known at the time.
== Ester terminology == IUPAC states normatively that carbamate "esters are often called urethanes or urethans, a usage that is strictly correct only for the ethyl esters." However, as a descriptive matter, the IUPAC recognizes that "An alternative term for the compounds R2NC(=O)OR' (R' not = H), esters of carbamic acids, R2NC(=O)OH, in strict use limited to the ethyl esters, but widely used in the general sense".
which makes radium, the heaviest alkaline earth element, well suited for constraining new physics beyond the standard model. Some radium isotopes, such as radium-225, have octupole deformed parity doublets that enhance sensitivity to charge parity violating new physics by two to three orders of magnitude compared to 199Hg. Radium is also a promising candidate for trapped ion optical clocks. The radium ion has two subhertz-linewidth transitions from the
Sources: en.wikipedia.org
The lyophilized powder is normally kept at minus twenty degrees Celsius or colder. Solutions are held at refrigerator temperature or below and protected from light. Repeated freezing and thawing is avoided because it can promote aggregation or loss of activity.
Reverse-phase liquid chromatography is used to assess purity, and mass spectrometry confirms molecular mass. Together these two checks form the most widespread approach. Some laboratories add amino acid analysis for further verification.
Yes. The peptide is freely soluble in water and in aqueous buffers, so reconstitution does not require an organic solvent. Stock solutions are usually prepared in water or a mild buffer. Exact handling depends on the intended downstream application.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.